Melatonin: a “Higgs boson” in human reproduction

References

• Cho A. The discovery of the Higgs boson. Science 2012;338:1524–5
   PubMed Web of Science ®Google Scholar
• Lerner AB, Case JD and Takahashi Yet al. Isolation of melatonin, the pineal gland factor that lightens melanocytes. J Am Chem Soc 1958;80:2587–92
   Web of Science ®Google Scholar
• Brzezinski A. Melatonin in humans. New Engl J Med 1997;336:186–95
   PubMed Web of Science ®Google Scholar
• Pang SF and Allen AE. Extra-pineal melatonin in the retina: its regulation and physiological function. Pineal Res Rev 1986;4:55–96
   Google Scholar
• Slominski A, Wortsman J and Tobin, DJ. The cutaneous serotoninergic/melatoninergic system securing a place under sun. FASEB J 2005;19:176–94
   PubMed Web of Science ®Google Scholar
• Bubenik GA. Gastrointestinal melatonin: localisation, function and clinical relevance. Dig Dis Sci 2002;47:2336–48
   PubMed Web of Science ®Google Scholar
• Conti A, Conconi S and Hertens Set al. Evidence of melatonin synthesis in mouse and human bone marrow cells. J Pineal Res 2000;28:193–202
   PubMed Web of Science ®Google Scholar
• Carrillo-Vicco A, Calvo JR and Abreu Pet al. Evidence of melatonin synthesis by human lymphocytes and its physiological significance: possible role in intracrine, autocrine, and/or paracrine substance. FASEB J 2004;18:537–9
   PubMed Web of Science ®Google Scholar
• Korkmaz A and Manchester LC. Reactive nitrogen species; devastating intracellular players and melatonin as a defender. J Exp Integr Med 2011;1:63–5
   Google Scholar
• Tan DX, Manchester LC, Hardeland R, Lopez-Burillo S and Mayo JC. Melatonin: a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin. J Pineal Res 2003;34:75–8
   PubMed Web of Science ®Google Scholar
• Gillette MU and Tischkau SA. Suprachiasmatic nucleus: the brain's circadian clock. Recent Prog Horm Res 1999;54:33–58
   PubMedGoogle Scholar
• Reiter RJ. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr Rev 1991;12:151–80
   PubMed Web of Science ®Google Scholar
• Cardinali DP and Pevet P. Basic aspects of melatonin action. Sleep Med Rev 1998;2:175–90
   PubMedGoogle Scholar
• Reiter RJ, Tan DX and Korkmaz A. The circadian melatonin rhythm and its modulation: possible impact on hypertension. J Hypertens Suppl 2009;27:17–20
   PubMedGoogle Scholar
• Srinivasan V, Maestroni GJ and Cardinali DPet al. Melatonin, immune function and aging. Immun Ageing 2005;2:1–10
   PubMedGoogle Scholar
• Korkmaz A, Tamura H and Manchester ICet al. Combination of melatonin and a peroxisome proliferator-activated receptor-gamma agonist induces apoptosis in a breast cancer cell line. J Pineal Res 2009;46:115–16
   PubMed Web of Science ®Google Scholar
• Droge W. Free radicals in the physiological control of cell function. Physiol Rev 2002;82:47–95
   PubMed Web of Science ®Google Scholar
• Brzezinski A, Seibel MM and Lynch HJet al. Melatonin in human preovulatory follicular fluid. J Clin Endocrinol Metab 1987;64:865–7
   PubMed Web of Science ®Google Scholar
• Tamura H, Nakamura Y and Takiguchi Set al. Pinealectomy of melatonin implantation does not affect prolactin surge or lutal function in pseudopregnant rats. Endocr J 1998; 45:377–83
   PubMed Web of Science ®Google Scholar
• Tamura H, Nakamura Y and Trron MPet al. Melatonin and pregnancy in the human. Reprod Toxicol 2008;25:291–303
   PubMed Web of Science ®Google Scholar
• Hattori A. The basic information for melatonin. Mod Physician 2007;27:1053–6
   Google Scholar
• Yonei Y, Hattori A and Tsutsui Ket al. Effects of melatonin: basic studies and clinical applications. Anti-aging Med 2010;7:85–91
   Google Scholar
• Pang SF, Li L and Ayre EAet al. Neuroendocrinology of melatonin n in reproduction: recent developments. J Clin Neuroanatomy 1998;14:157–66
   PubMed Web of Science ®Google Scholar
• Berson DM, Dunn FA and Takao M. Phototransduction by retinal ganglion cells that set the circadian clock. Science 2002;295:1070–3
   PubMed Web of Science ®Google Scholar
• Gerdin MJ, Masana MI and Rivera-Bermudez MAet al. Melatonin desensitizes endogenous MT2 melatonin receptors in the rat suprachiasmatic nucleus. Relevance for defining the periods of sensitivity of the mammalian circadian clock to melatonin. FASEB J 2004;18:1646–56
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Gultekin F and Flores LJet al. Melatonin: potential utility for improving public health. TAF Prev Med Bull 2006;5:131–58
   Google Scholar
• Dullo P and Chaudhary R. Short review of reproductive physiology of melatonin. Pak J Physiol 2009;5:46–8
   Google Scholar
• Dubocovich ML and Markowska M. Functional MT1 and MT2 melatonin receptors in mammals. Endocrine 2005;27:101–10
   PubMed Web of Science ®Google Scholar
• Nosjean O, Ferro M and Coge Fet al. Identification of the melatonin-binding site MT3 as the quinone reductase 2. J Biol Chem 2000;275:31311–17
   PubMed Web of Science ®Google Scholar
• Wiesenberg I, Missbach M and Carlberg C. The potential role of the transcrition factor RZR/ROR as a mediator of nuclear melatonin signaling. Restor Neurol Neurosci 1998;12:143–50
   PubMed Web of Science ®Google Scholar
• Benitez-King G. Melatonin as a cytoskeletal modulator: implications for cell physiology and disease. J Pineal Res 2006;40:1–9
   PubMed Web of Science ®Google Scholar
• Calberg C. Gene regulation by melatonin. Ann N Y Acad Sci 2000;917:387–96
   PubMed Web of Science ®Google Scholar
• Ishii H, Tanaka N and Kobayashi M. Gene structures, biochemical characterization and distribution of rat melatonin receptors. J Physiol Sci 2009;59:37–47
   PubMed Web of Science ®Google Scholar
• Srinivasan V, Spence WD and Pandi-Perumal SRet al. Melatonin and human reproduction: shedding light on the darkness hormone. Gynecol Endocrinol 2009;25:779–85
   PubMed Web of Science ®Google Scholar
• Boczek-Leszczyk E and Juszczak M. The influence of melatonin on human reproduction. Pol Merkur Lekarski 2007;23:128–30
   PubMedGoogle Scholar
• Wojtowicz M and Jakiei G. Melatonin and its role in human reproduction. Ginekol Pol 2002;73:1231–7
   PubMedGoogle Scholar
• Maganhin CC, Carbonel AA and Hatty JHet al. Melatonin effects on the female genital system: a brief review. Rev Assoc Med Bras 2008;54:267–71
   PubMed Web of Science ®Google Scholar
• Pandi-Perumal SR, Trakht I, Srinivasan V and Spence DWet al. Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways. Prog Neurobiol 2008;85:335–53
   PubMed Web of Science ®Google Scholar
• Zemkova H and Vanecek J. Inhibitory effect of melatonin on gonadotrophin-releasing hormone induced Ca2+ oscillations in pituitary cells of newborn rats. Neuroendocrinology 1997;65:276–83
   PubMed Web of Science ®Google Scholar
• Malpaux B, Migaud M, Tricoire R and Chemineau P. Biology of mammalian photoperiodism and the critical role of pineal gland and melatonin. J Biol Rhytms 2001;16:336–47
   PubMed Web of Science ®Google Scholar
• Bentley GE, Ubuka T and McGuire NLet al. GnRH: a multifunctional neuropeptide. J Neuroendocrinol 2009;21: 276–8
   PubMed Web of Science ®Google Scholar
• Silman RE. Melatonin and the human gonadotrophin-releasing hormone pulse generator. J Endocrinol 1991;128:7–11
   PubMed Web of Science ®Google Scholar
• Waldhauser F, Boepple PA and Schemper Met al. Serum melatonin in central precocious puberty is lower than in age-matched prepubertal. J Clin Endocrinol Metab 1991;73:793–6
   PubMed Web of Science ®Google Scholar
• Cavallo A. Melatonin and human puberty: current perspectives. J Pineal Res 1993;15:115–21
   PubMed Web of Science ®Google Scholar
• Brzezinski A. Melatonin and human reproduction: why the effect is so elusive? In: Pandy-Perumal SR and Cardinali DP, eds. Melatonin: from molecules to therapy. New York: Nova Science Publishers; 2007:219–25
   Google Scholar
• Reiter RJ, Tan DX and Manchester LCet al. Melatonin and reproduction revised. Biol Reprod 2009;81:445–56
   PubMed Web of Science ®Google Scholar
• Richards JS and Panges SA. The ovary: basic biology and clinical implications. J Clin Invest 2010;120:963–72
   PubMed Web of Science ®Google Scholar
• Soares Jr JM, Masana MI, Ersahin C and Dubovich ML. Functional melatonin receptors in rat ovaries at various stages of th estrous cycle. J Pharmacol Exp Ther 2003;306:694–702
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Tan DX and Fuentes-Broto L. Melatonin: a multitasking molecule. Prog Brain Res 2010;181:127–51
   PubMed Web of Science ®Google Scholar
• Tamura H, Nakamura Y and Korkmaz Aet al. Melatonin and the ovary: physiological and pathological implications. Fertil Steril 2009;92:328–43
   PubMed Web of Science ®Google Scholar
• Tan DX, Manchester LC, Terron MP and Reiter RJ. One molecule, many derivates: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 2007;42:28–42
   PubMed Web of Science ®Google Scholar
• Tamura H, Takasaki A and Taketani Tet al. Melatonin as free radical scavenger in the ovarian follicle. Endocr J 2013;60:1–13
   PubMed Web of Science ®Google Scholar
• Tamura H, Nakamura Y and Terron MPet al. Melatonin and pregnancy in the human. Reprod Toxicol 2008;25:291–303
   PubMed Web of Science ®Google Scholar
• Espey LL. Current status of the hypothesis that mammalian ovulation is comparable to an inflammatory reaction. Biol Reprod 1994;50:233–8
   PubMed Web of Science ®Google Scholar
• Droge W. Free radicals in the physiological control of cell function. Physiol Rev 2002;82:47–95
   PubMed Web of Science ®Google Scholar
• Hensley K, Robinson KA and Gabbita SPet al. Reactive oxygen species, cell signaling, and cell injury. Free Radic Biol Med 2000;28:1456–62
   PubMed Web of Science ®Google Scholar
• Fetehi AN, Roelen BA and Colenbrander Bet al. Presence of cumulus cells during in vitro fertilization protects the bovine oocyte against oxidative stress and improves first cleavage but does not affect further development. Zygote 2005;13:177–85
   PubMed Web of Science ®Google Scholar
• Tatemoto H, Muto N and Sunagawa Iet al. Protection of porcine oocytes against cell damage caused by oxidative stress during in vitro maturation: role of superoxide dismutase activity in porcine follicular fluid. Biol Reprod 2004;71:1150–7
   PubMed Web of Science ®Google Scholar
• Guerin P, El Mouatassim S and Menezo Y. Oxidative stress and protection against reactive oxygen species in the pre-implantation embryo and its surroundings. Hum Reprod Update 2001;7:175–89
   PubMed Web of Science ®Google Scholar
• Ishizuka B, Kuribayashi Y and Murai Ket al. The effect of melatonin on in vitro fertilization and embryo development in mice. J Pineal Res 2000;28:48–51
   PubMed Web of Science ®Google Scholar
• Tamura H, Takasaki A and Taketani Tet al. The role of melatonin as an antioxidant in the follicle. J Ovarian Res 2012;5:1–9
   PubMed Web of Science ®Google Scholar
• Tamura H, Takasaki A and Miwa Iet al. Oxidative stress impairs oocyte quality and melatonin protects oocyte from free radical damage and improves fertilization rates. J Pineal Res 2008;44:280–7
   PubMed Web of Science ®Google Scholar
• Walsh SW and Wang Y. Secretion of lipid peroxides by the human placenta. Am J Obstet Gynecol 1993;169:1462–6
   PubMed Web of Science ®Google Scholar
• Mover-Lev H and Ar A. Changes in enzymatic antioxidant activity in pregnant rats exposed to hyperoxia. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 1997;118:353–9
   PubMed Web of Science ®Google Scholar
• Milczarek R, Klimek J and Zelewski L. Melatonin inhibits NADPH-dependent lipid peroxidation in human placental mitochondria. Horm Metab Res 2000;32:84–5
   PubMed Web of Science ®Google Scholar
• Nagai R, Watanabe K and Wakatsuki Aet al. Melatonin preserves fetal growth in rats by protecting against ischemia/reperfusion-induced oxidative/nitrosative mitochondrial damage in the placenta. J Pineal Res 2008;45:271–6
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Tamura H and Kashida Set al. Changes of serum melatonin level and its relationship to fetoplacental unit during pregnancy. J Pineal Res 2001;30:29–33
   PubMed Web of Science ®Google Scholar
• Shenker S, Yang Y and Perez Aet al. Antioxidant transport by the human placenta. Clin Nutr 1998;17:159–67
   PubMed Web of Science ®Google Scholar
• Thomas L, Purvis CC and Drew JEet al. Melatonin receptors in human fetal brain: 2-[(125)I]iodomelatonin binding and MT1 gene expression. J Pineal Res 2002;33:218–24
   PubMed Web of Science ®Google Scholar
• Okatani Y, Watanabe K and Hayashi Ket al. Melatonin inhibits vasospastic action of hydrogen peroxide in human umbilical artery. J Pineal Res 1997;22:163–8
   PubMed Web of Science ®Google Scholar
• Brown MA, Lindheimer MD and de Swiet Met al. The classification and the diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001;20:9–14
   Web of Science ®Google Scholar
• Fait V, Sela S and Ophir Eet al. Hyperemesis gravidarum is associated with oxidative stress. Am J Perinatol 2002;19:93–8
   PubMed Web of Science ®Google Scholar
• Myatt L and Cui X. Oxidative stress in placenta. Histochem Cell Biol 2004;122:369–82
   PubMed Web of Science ®Google Scholar
• Vanderlelie J, Venardos K and Clifton VLet al. Increased biological oxidation and reduced anti-oxidant enzyme activity in pre-eclamptic placentae. Placenta 2005;26:53–8
   PubMed Web of Science ®Google Scholar
• Simko F and Paulis L. Melatonin as a potential antihypertensive treatment. J Pineal Res 2007; 42:319–22
   PubMed Web of Science ®Google Scholar
• Pagni CA and Zenga F. Posttraumatic epilepsy with special emphasis on prophylaxis and prevention. Acta Neurochir Suppl 2005;93:27–34
   PubMedGoogle Scholar
• Gupta S, Agarwai A, Banerjee J and Alvarez JG. The role of oxidative stress in spontaneous abortion and recurrent pregnancy loss: a systematic review. Obstet Gynecol Surv 2007;62:335–47
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Tamura H and Kashida Set al. Changes of serum melatonin level and its relationship to feto-placental unit during pregnancy. J Pineal Res 2001;30:29–33
   PubMed Web of Science ®Google Scholar
• Sharkey JT, Puttaramu R, Word RA and Olcese J. Melatonin synergizes with oxytocin to enhance contractility of human myometrial smooth muscle cells. J Clin Endocrinol Metab 2009;94:421–7
   PubMed Web of Science ®Google Scholar
• Carlomagno G, Nordio M, Chiu TT and Unfer V. Contribution of myo-inositol and melatonin to human reproduction. Eur J Obstet Gynecol Reprod Biol 2012;159:267–72
   Web of Science ®Google Scholar
• WHO Scientific Group. Research on the Menopause in the 1990s. WHO Technical Report Series No 866. Geneva:WHO; 1996
   Google Scholar
• Pines A, Sturdee DW and MacLennan AHet al. The heart of the WHI study: time for hormone therapy policies to be revised. Climacteric 2007;10:267–9
   PubMed Web of Science ®Google Scholar
• Anderson E, Hamburger S, Liu JH and Rebr RW. Characteristics of menopausal women seeking assistance. Am J Obstet Gynecol 1987;156:428–33
   PubMed Web of Science ®Google Scholar
• Williams RE, Levine KB and Kalilani Let al. Menopause-specific questionnaire assessment in US population-based studz shows negative impact on health-related quality of life. Maturitas 2009;62:153–9
   PubMed Web of Science ®Google Scholar
• Pollycove R, Naftolin F and Simon JA. The evolutionary origin and significance of menopause. Menopause 2011;18:336–42
   PubMed Web of Science ®Google Scholar
• Archer DF, Baber RJ and Barlow Det al. Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric 2011;14:302–20
   PubMed Web of Science ®Google Scholar
• De Villiers TJ, Gass MLS and Haines CJet al. Global consensus statement on menopausal hormone therapy. Climacteric 2013;16:203–4
   PubMed Web of Science ®Google Scholar
• Bellipani G, Marzo F, Blasi F and Di Marzo A. Effects of melatonin in perimenopausal and menopausal women: our personal experience. Ann N Y Acad Sci 2005;1057:393–402
   PubMed Web of Science ®Google Scholar
• Satomura K, Tobiume S and Tokuyama Ret al. Melatonin at pharmacological doses enhances human osteoblastic differentiation in vitro and promotes mouse cortical bone formation in vivo. J Pineal Res 2007;42:231–9
   PubMed Web of Science ®Google Scholar
• Reiter RJ and Korkmaz A. Clinical aspects of melatonin. Saudi Med J 2008;29:1537–47
   PubMed Web of Science ®Google Scholar
• Rodriguez MI, Escames G and López Let al. Chronic melatonin treatment reduces the age-dependent inflammatory process in senescence-accelerated mice. J Pineal Res 2007;42:272–9
   PubMed Web of Science ®Google Scholar
• Masilamoni JG, Jesudason EP and Dhandayuthapani Set al. The neuroprotective role of melatonin against amyloid beta peptide injected mice. Free Radical Res 2008;42:661–73
   PubMed Web of Science ®Google Scholar
• Stevens RG. Circadian disruption and breast cancer: from melatonin to clock genes. Epidemiology 2005;16:254–8
   PubMed Web of Science ®Google Scholar
• Girgert R, Hanf V, Emons G and Gründker C. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells. J Pineal Res 2009;47:23–31
   PubMed Web of Science ®Google Scholar
• Jan JE, Reiter RJ, Wasdell MB and Bax M. The role of the thalamus in sleep, pineal melatonin production, and circadian rhythm sleep disorders. J Pineal Res 2009;46:1–7
   PubMed Web of Science ®Google Scholar
• Brzezinski A, Vangel MG and Wurtman RJet al. Effects of exogenous melatonin on sleep: a meta analysis. Sleep Med Rev 2005;9:41–50
   PubMed Web of Science ®Google Scholar
• Srinivasan V, Cardinali DP, Pandi-Perumal SR and Brown GM. Melatonin agonists for treatment of sleep and depressive disorders. J Exp Integr Med 2011;1:149–58
   Google Scholar
• Roth T, Seiden D and Sainati Set al. Effects of ramelteon on patient-reported sleep latency in older adults chronic insomnia. Sleep Med 2006;7:312–18
   PubMed Web of Science ®Google Scholar
• Guillenminault C. Efficacy of agomelatine versus venlafaxine on subjective sleep of patients of major depressive disorder. Eur Neuropsychopharmacol 2005;15:419–20
   Web of Science ®Google Scholar
• Burnet M. Somatic mutation and chronic disease. Br Med J 1965;1:338–42
   PubMedGoogle Scholar
• Cardinalli DP, Esquino AI, Srinivasan V and Pandi-Perumal SR. Melatonin and the immune system in aging. Neuroimmunomodulation 2008;15:272–8
   PubMed Web of Science ®Google Scholar
• Nelson RJ and Drazen DL. Melatonin mediates seasonal changes in immune function. Ann N Y Acad Sci 2000;917:404–15
   PubMed Web of Science ®Google Scholar
• Lardone PJ, Carrillo-Vico A and Naranjo MCet al. Melatonin synthesized by Jurkat human leukemic T cell line is implicated in IL-2 production. J Cell Physyiol 2006;206:273–9
   PubMed Web of Science ®Google Scholar
• Garcia-Maurino S, Pozo D, Calvo JR and Guerrero JM. Correlation between nuclear melatonin receptor expression and enhanced cytokine production in human lymphocytes and monocytic cell lines. J Pineal Res 2000;29:129–37
   PubMed Web of Science ®Google Scholar
• Currier NL, Sun LZ and Miller SC. Exogenous melatonin: quantitative enhancement in vivo of cells mediating non.specific immunity. J Neuroimmunol 2000;104:101–8
   PubMed Web of Science ®Google Scholar
• Maestroni GJ, Covacci V and Conti A. Hematopoietic rescue via T-cell-dependent, endogenous granulocyte-macrophage colony-stimulating factor induced by the pineal neurohormone melatonin in tumor-bearing mice. Cancer Res 1994;54:2429–32
   PubMed Web of Science ®Google Scholar
• Herberman RB and Ortaldo JR. Natural killer cells: their roles in defenses against disease. Science 1981;214:24–30
   PubMed Web of Science ®Google Scholar
• Garcia-Maurino S, Gonzales-Haba MG and Calvo JRet al. Melatonin enhances IL-2, IL-6, and IFN-gamma production by human circulating CD4+ cells: a possible nuclear receptor-mediated mechanism involving T helper type 1 lymphocytes and monocytes. J Immunol 1997;159:574–81
   PubMed Web of Science ®Google Scholar
• Jiang H and Chess L. An integrated view of suppresor T cell subset in immunoregulation. J Clin Invest 2004;114:1198–208
   PubMed Web of Science ®Google Scholar
• Ossendorp F, Toes RE and Offringa Ret al. Importance of CD4+ T helper cell responses in tumor immunity. Immunol Lett 2000;74:75–9
   PubMed Web of Science ®Google Scholar
• Knutson KL and Disis ML. Tumor antigen-specific T helper cells in cancer immunity and immunotherapy. Cancer Immunol Immunother 2005;54:721–8
   PubMed Web of Science ®Google Scholar
• Raghavendra V, Singh V, Kulkarni SK and Agrewala JN. Melatonin enhances Th-2 cell mediated immune responses: lack of sensitivity to reversal by naltrexone or benzodiapine receptor antagonist. Mol Cell Biochem 2001;221:57–62
   PubMed Web of Science ®Google Scholar
• Srinivasan V, Pandi-Perumal SR and Brzezinski Aet al. Melatonin, immune function and cancer. Recent Pat Endocr Metab Immune Drug Discov 2011;5:109–23
   Google Scholar
• Karbownik M, Lewinski A and Reiter RJ. Anticarcinogenic actions of melatonin which involve antioxidative processes: comparison with other antioxidants. Int J Biochem Cell Biol 2001;33:735–53
   PubMed Web of Science ®Google Scholar
• Karbownik M, Reiter RJ and Burkhardt Set al. Melatonin attenuates estradiol-induced oxidative damage to DNA: relation to cancer prevention. Exp Biol Med 2001;226:707–12
   PubMed Web of Science ®Google Scholar
• Reiter RJ. Potential biological consequences of excessive light exposure: melatonin suppression, DNA damage, cancer and neurodegenerative disease. Neuroendocrinol Lett 2002;23:9–13
   PubMed Web of Science ®Google Scholar
• Vijayalaxmi Dr, Thomas Jr CR, Reiter RJ and Herman TS. Melatonin: from basic research to cancer treatment clinics. J Clin Oncol 2002;20:2575–601
   PubMed Web of Science ®Google Scholar
• Blask DE, Dauchy RT and Sauer LA. Putting cancer to sleep at night: the neuroendocrine/circadian melatonin signal. Endocrine 2005;27:179–88
   PubMed Web of Science ®Google Scholar
• Mills F, Wu P, Seely D and Guyott G. Melatonin in the treatment of cancer: a systematic review of randomized trials and meta-analysis. J Pineal Res 2005;39:360–6
   PubMed Web of Science ®Google Scholar
• Cabrera J, Negrin G and Estevez Fet al. Melatonin decreases cell proliferation and induces melanogenesis in human melanoma SK-MEL-1 cells. J Pineal Res 2010;49:45–54
   PubMed Web of Science ®Google Scholar
• Karasek M, Kowalski AJ and Zylinska K. Serum melatonin circadian profile in women suffering from the genital tract cancers. Neuro Endocrinol Lett 2000;21:109–13
   PubMed Web of Science ®Google Scholar
• Winczyk K, Fuss-Chmielewska J and Lawnicka Het al. Luzindole but not 4-phenyl-2-propionamidotetralin (4P-PDOT) diminishes the inhibitory effect of melatonin on murine Colon 38 cancer growth in vitro. Neuroendocrinol Lett 2009;30:657–62
   PubMed Web of Science ®Google Scholar
• Molis TM, Spriggs LL, Jupiter Y and Hill SM. Melatonin modulation of estrogen-related proteins, growth factors, and proto-oncogenesis in human breast cancer. J Pineal Res 1995;18:93–103
   PubMed Web of Science ®Google Scholar
• Blask DE, Brainard GC and Dauchy RTet al. Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. Cancer Res 2005;65:11174–84
   PubMed Web of Science ®Google Scholar
• Blask DE, Dauchy RT, Brainard GC and Hanifin JP. Circadian stage-dependent inhibition of human breast cancer metabolism and growth by the nocturnal melatonin signal: consequences of its disruption by light at night in rats and women. Integr Cancer Ther 2009;8:347–53
   PubMed Web of Science ®Google Scholar
• Anisimov VN, Popovich IG and Zabezhinski MAet al. Melatonin as antioxidant, geroprotector and anticarcinogen. Biochem Biophys Acta 2006;1757:573–89
   PubMed Web of Science ®Google Scholar
• Greider CW and Blackburn EH. Identification of specific telomere terminal transferase activity in tetrahymena extracts. Cell 1985;43:405–13
   PubMed Web of Science ®Google Scholar
• Knowles J, Loizidou M and Taylor I. Endothelin-1 and angiogenesis in cancer. Curr Vasc Pharmacol 2005;3:309–14
   PubMedGoogle Scholar
• Kilic E, Kilic U and Reiter RJet al. Prophylactic use of melatonin protects against focal cerebral ischemia in mice: role of endothelin converting enzyme-1. J Pineal Res 2004;37:247–51
   PubMed Web of Science ®Google Scholar
• Schernhammer ES, Berrino F and Krough Vet al. Urinary 6-Sulphatoxymelatonin levels and risk of breast cancer in premenopausal women: the ORDET cohort. Cancer Epidemiol Biomarkers Prev 2010;19:729–37
   PubMed Web of Science ®Google Scholar
• Bartsch C, Bartsch H and Jain AKet al. Urinary melatonin levels in human breast cancer patients. J Neural Transm 1981;52:281–94
   PubMed Web of Science ®Google Scholar
• Sanchez-Barcelo EJ, Cos S and Mediavilla Det al. Melatonin-estrogen interactions in breast cancer. J Pineal Res 2005;38:217–22
   PubMed Web of Science ®Google Scholar
• Cos S, Gonzalez A and Martinez-Campa Cet al. Melatonin as a selective estrogen enzyme modulator. Curr Cancer Drug Targets 2008;8:691–702
   PubMed Web of Science ®Google Scholar
• Reiter JR, Rosales-Corral AS, Manchester CL and Tan DX. Peripheral reproductive organ health and melatonin: ready for prime time. Int J Mol Sci 2013;14:7231–72
   PubMed Web of Science ®Google Scholar